Achyut Healthcare Ltd, a rising SME stock, has announced a stock split and bonus issue for shareholders. These corporate actions aim to improve liquidity and enhance shareholder value. The healthcare stock, which has delivered multibagger returns of over 300% in recent years, continues to attract investor attention. Below, we break down the details of the stock split, bonus issue, and the company’s recent financial performance.
Stock Split and Bonus Issue Details
Achyut Healthcare’s Board of Directors has approved two major proposals:
- Stock Split:
- Each equity share with a face value of ₹10 will be subdivided into ten equity shares with a face value of ₹1.
- The subdivision will increase the number of shares in circulation, enhancing liquidity.
- Bonus Issue:
- The company will issue four bonus shares for every ten shares held (4:10 ratio) after the stock split.
- Both the stock split and bonus issue have the same record date: Tuesday, December 10, 2024.
These measures aim to make the stock more affordable and accessible to investors while increasing shareholder value.
About Achyut Healthcare
Founded in 1996, Achyut Healthcare Ltd is a pharmaceutical trading company specializing in APIs, pharmaceutical products, and medical devices. The company also manufactures pharmaceutical formulations, including tablets, capsules, oral liquids, and injectables. As of June 2024, Achyut Healthcare is debt-free, with a market capitalization of ₹128.29 crore.
Financial Performance
The company’s financials reflect strong growth and profitability:
- Q2FY25 vs. Q2FY24:
- Net sales increased by 44% to ₹2.13 crore.
- Net profit rose by 35% to ₹1.48 crore.
- Annual Results (FY24):
- Net sales reached ₹6.14 crore.
- Net profit stood at ₹0.66 crore, highlighting consistent annual growth.
Leave a Reply